Tin tức & Cập nhật
Xem bài viết Nhãn khoa
Xem
Chỉ hiển thị Multimedia

NVAMD risk tied to semaglutide no different from other antidiabetes medications
01 Nov 2026
bởiStephen Padilla
The risk of neovascular age-related macular degeneration (NVAMD) associated with the use of semaglutide is similar to that with other glucagon-like peptide-1 receptor agonists (GLP-1 RAs) or non-GLP-1 RAs among adults with type 2 diabetes (T2D), suggests a study.
01 Nov 2026

Tebentafusp delivers 5-year survival benefit in metastatic uveal melanoma
08 Sep 2026
bởiStephen Padilla
Long-term survival benefits with tebentafusp persist in previously untreated HLA-A∗02:01-positive patients with unresectable or metastatic uveal melanoma (mUM), as shown in the longest survival follow-up of a phase III trial.
08 Sep 2026






